InvestorsHub Logo
Followers 163
Posts 12837
Boards Moderated 1
Alias Born 01/26/2016

Re: dstock07734 post# 692487

Sunday, 05/19/2024 7:12:10 PM

Sunday, May 19, 2024 7:12:10 PM

Post# of 695558
dstock07734,

Look at the Nivo numbers again. Subcutaneous Nivo had more deaths confirmed related to drug toxicity (3) vs IV (1) with only one patient difference in enrollment. We now know that two different SC versions have come out with toxicity numbers that slightly favor IV vs SC delivery. This SC adverse events trend is not favorable to patients or safety first when considering safety of IV vs SC. Best wishes.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News